Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors.

Publication

Citation
Bryan MC, Drobnick J, Gobbi A, Kolesnikov A, Chen Y, Rajapaksa N, Ndubaku C, Feng J, Chang W, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Huang Z, Sujatha-Bhaskar S, Brightbill H, DiPasquale A, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR.: Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. J Med Chem, Volume 62 (13), 2019
Authors
An L, Brightbill H, Bryan MC, Chang W, Chen Y, Choo EF, DeMent K, DiPasquale A, Drobnick J, Emson C, Feng J, Francis R, Gobbi A, Huang Z, Kiefer JR., Kolesnikov A, Lupardus PJ, Maher J, McKenzie BS, Ndubaku C, Rajapaksa N, Ran Y, Sujatha-Bhaskar S, Wai J, Yu C, Zarrin AA
Journal
J Med Chem
Year
2019
PubMed
31082230
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc